Is the Oxygen Prescription Still Right? Evidence Between Visits

Home oxygen is one of the most consequential prescriptions in respiratory care. It shapes how a patient moves, sleeps, travels and lives. Yet once it is ordered, it is often renewed with remarkably little information about how it is actually being used or whether the original setting still fits the patient in front of the prescriber.

That is not a failure of the clinician. It is a failure of visibility. A prescriber sees the patient for a few minutes a year and is asked to judge whether the therapy is working, whether the patient is using it, and whether it is worth continuing. Between those visits, nothing reports back.

The questions a renewal should answer

Respiratory therapists frame the problem with a short set of questions that apply to any therapy, and oxygen is no exception:

• Is the therapy being used?
• Is it working?
• Can it be adjusted?
• Are there adjunctive options?
• What else can the patient do?

Each of these is easier to answer with a record of the patient’s ordinary days than with a single office reading. A patient may describe a good week at the appointment and leave out the three difficult nights before it. A device may sit unused on the weekends. A change in breathlessness may develop slowly enough that nobody notices until it becomes an emergency department visit.

Turning daily answers into evidence

PDS™, the Patient Data System inside CareConnect™, was designed for exactly this gap. It follows a Practice-Based Protocol approach: the care team customizes the questions, and the patient answers them on the phone they already carry in about thirty seconds a day. For an oxygen patient, a care team might ask about use of the therapy, breathlessness on a simple scale, activity, or any other measure the prescriber considers useful. We explain the mechanics in PDS™: Turning Thirty Seconds of Patient Answers into Clinical Evidence.

The care team, not EBM, decides what counts as out of range for each patient’s care plan. When an answer falls outside it, an alert is raised the same day. Fourteen-day trends show whether a pattern is forming. Over weeks and months, the prescriber has something they rarely have at renewal time: evidence of how the therapy is performing in the patient’s real life.

Overnight insight with Hybrid Overnight Oximetry

Daily questions capture how the patient feels and what they do. Some decisions also need objective overnight information. Hybrid Overnight Oximetry is a Practice-Based Protocol approach to cardio-pulmonary disease that runs from screening through management of therapeutics such as oxygen therapy and CPAP. Combined with daily patient answers, it gives the care team a fuller picture of whether a prescription still fits. Read more in Hybrid Overnight Oximetry: A Practice-Based Protocol for Cardio-Pulmonary Care.

None of this replaces clinical judgment. It informs it. The prescriber remains in control of every decision; the platform simply makes sure that decision is grounded in what actually happened between visits.

Why this matters to the respiratory department

For respiratory therapists, evidence between visits extends their expertise well beyond the bedside. An RT reviewing a trend can identify a patient who is struggling with a device, coordinate with the prescriber, and document the work, with time spent reviewing and acting captured automatically. We describe that expanded role for Health Care Professionals.

For hospital leadership, the case is equally direct. Respiratory patients who deteriorate quietly at home are the patients who return. COPD is among the conditions measured under the CMS Hospital Readmissions Reduction Program, which can reduce a hospital’s base Medicare payments by up to 3%. A program designed to surface problems earlier supports the department’s clinical mission and the hospital’s financial one.

Simple to start

Because PDS™ requires no CPT codes and no payer qualification, and places no limits on who can participate, a department can include every oxygen patient rather than a qualifying subset. EBM Health Care Strategies provides the platform and the tools, with no hiring, no equipment purchases and no IT build-out. The cost per patient is a small fraction of what a single office visit reimburses.

The goal is not more data for its own sake. It is a better answer to a question every prescriber faces: is this oxygen prescription still right for this patient today?